Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients

An already unfavorable lipid and HDL subpopulation profile of HIV-positive HAART-naïve subjects further deteriorated after receiving PI-based treatment, which may cause increased CHD-risk in these subjects.